Pilot Study of a Novel 532nm KTP Laser for the Treatment of Fresh Surgical Scars

Inclusion Criteria: * Fitzpatrick Skin Type I - IV * Has postoperative linear scar(s) which is one to twelve months post-surgery. * Having one scar that measures a minimum of 5 cm in length or two scars (bilateral) each measure a minimum of 2 cm in length. * Be in good health. * Must agree not to undergo any other procedure for the treatment of scar during the study. * Willing to refrain from excess sun exposure and willing to wear sunscreen on the treated scar during the study (including the follow-up period). * Able to read, understand and sign the Informed Consent Form. * Willing and able to adhere to the treatment and follow-up schedule, and the post-treatment care instructions. * Willingness to have digital photographs taken of the treated scar. * Post-menopausal or surgically sterilized, or using a medically acceptable form of birth control at least 3 months prior to enrollment and during the entire course of the study. Exclusion Criteria: * Participation in a study of another device or drug within 6 months prior to enrollment or during the study. * Having received any prior treatment for the target surgical scar. * Pregnant and/or breastfeeding. * Significant concurrent illness, malignant tumors in the target area, acute or chronic skin infection/inflammation, currently using immunosuppressive medications or currently undergoing systemic chemotherapy. * Current use of any medication known to increase sensitivity to light or taking prescription anticoagulation medication. * History of abnormal or delayed wound healing, keloid formation or pigmentary disorders, particularly tendency for hyper- or hypo-pigmentation. * History of malignant skin disease, immune deficiency disorders, coagulation disorders, seizure disorders due to light, or diseases stimulated by heat, unless prophylactic measures taken prior to treatment. * Systemic use of isotretinoin within 6 months or corticosteroids within 12 months of study participation. * Anytime in life, had used gold therapy (gold salts) for disorders such as rheumatologic disease or lupus. * Current smoker or history of smoking within 12 months of study participation.